BDP® 650/665 alkyne

Cat. # Quantity Price Lead time
A84B0 1 mg $125 in stock
B84B0 5 mg $260 in stock
C84B0 10 mg $325 in stock
D84B0 25 mg $510 in stock
E84B0 50 mg $895 in stock
F84B0 100 mg $1490 in stock
Found better price? Let us know and we will propose the way forward!

BDP 650/665 alkyne is a red-emitting BDP dye derivative carrying a terminal alkyne group for a copper-catalyzed conjugation with azides. Absorption and emission spectra of BDP 650/665 are designed to fit Cy5-channel of various instruments.

Absorption and emission spectra of BDP 650/665

Absorption and emission spectra of BDP 650/665

Customers also purchased with this product

BDP® 650/665 azide

BDP 650/665 is a red-emitting borondipyrromethene dye. This azide derivative can be conjugated with alkynes and cycloalkynes.

BDP® TMR alkyne

Borondipyrromethene dye for TAMRA channel, with alkyne group for copper-catalyzed click chemistry.

BDP® 630/650 azide

BDP 630/650 is a bright borondipyrromethene-based fluorophore for the far red area of the spectrum. It possesses a high extinction coefficient and quantum yield. This is an azide for сlick chemistry labeling.

General properties

Appearance: dark colored solid
Molecular weight: 470.28
CAS number: 2006345-40-8
Molecular formula: C26H21N4BF2O2
Solubility: soluble in DMF, DMSO
Quality control: NMR 1H, HPLC-MS (95%)
Storage conditions: Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS: Download
Product specifications

Spectral properties

Excitation/absorption maximum, nm: 649
ε, L⋅mol−1⋅cm−1: 94000
Emission maximum, nm: 667
Fluorescence quantum yield: 0.52
CF260: 0.04
CF280: 0.04

Product citations

  1. Iacobazzi, R.M.; Arduino, I.; Di Fonte, R.; Lopedota, A.A.; Serratì, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B.-C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A. Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights. Cancers, 2022, 14(1), 5. doi: 10.3390/cancers14010005
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.